Afolarin A Otunla (Afolarin Otunla)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

British journal of clinical pharmacology

Liver international : official journal of the International Association for the Study of the Liver

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Lee, Afolarin A Otunla, Isabelle Brennan, Jeffrey K Aronson, David Nunan
Clinical trials of pharmacological interventions for SARS-CoV-2 published in leading medical journals report adherence but not how it was assessed. British journal of clinical pharmacology 90 (4) (2024)
Charlotte Lee, Afolarin A Otunla, Isabelle Brennan, Jeffrey K Aronson, David Nunan
Clinical trials of pharmacological interventions for SARS-CoV-2 published in leading medical journals report adherence but not how it was assessed. British journal of clinical pharmacology 90 (4) (2024)
Charlotte Lee, Afolarin A Otunla, Isabelle Brennan, Jeffrey K Aronson, David Nunan
Clinical trials of pharmacological interventions for SARS-CoV-2 published in leading medical journals report adherence but not how it was assessed. British journal of clinical pharmacology (2023)
Sarah Nabulsi, Afolarin A Otunla, Justin Salciccioli, Dominic C Marshall, Vincenzo Villani, Kumaran Shanmugarajah, Joseph Shalhoub
HLA matching between donors and recipients improves clinical liver transplant graft survival. Liver international : official journal of the International Association for the Study of the Liver (2023)
Lauren L O'Mahoney, Patrick J Highton, Laura Kudlek, Jessica Morgan, Rosie Lynch, Ella Schofield, Nayanika Sreejith, Ajay Kapur, Afolarin A Otunla, Sven Kerneis, Olivia James, Karen Rees, Ffion Curtis, Kamlesh Khunti F MedSci, Jamie Hartmann-Boyce
The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 24 (9) (2022)